FDA recall,
Sagent Pharmaceuticals Famotidine Injection
Famotidine Injection contains tiny pieces of material that do not belong in the product.
What happened
Sagent Pharmaceuticals, based in Schaumburg, Illinois, began a voluntary recall of 1,720 vials of Famotidine Injection on October 22, 2026. The company started the recall on its own. The recall was made because of tiny pieces of material that do not belong in the product.
The product was distributed nationwide in the US. Customers were told about the recall by letter. The agency added the recall to its Enforcement Report on November 3, 2026, and included it in its weekly enforcement report on November 11, 2026.
What to do
If a code on your package is listed below:
- Don't stop taking it without talking to your pharmacist or doctor; ask them whether your lot is recalled.
Typical advice for a recalled medicine; the FDA notice gives no product-specific instructions.
Is yours affected?
Match the lot code and NDC listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Famotidine Injection
- Strength
- 200 mg
- NDC
- 25021-756-50
- Lot code
- E243A001
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Nov 2, 2026
- Sold in
Distributed nationwide.
- Recalled by
- Sagent PharmaceuticalsSchaumburg, Illinois
- Hazard
- Foreign object
- Risk
Not yet rated by FDA
- FDA event number
- 100208
- Quantity recalled
- 1,720 vials
- Recall type
- Started by the company
- How the company first told customers
- Letter
All recalls from Sagent Pharmaceuticals
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Sagent Pharmaceuticals began the recall
FDA posted the recall to its Enforcement Report
Added to Recall Canary
Summary updated

